Redfern H Charles MD is categorized under Physicians Offices in San Diego, CA and active since 2004.
Redfern H Charles MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact H Charles Redfern at the company’s single location by writing to 3075 Health Center Drive # 102, San Diego, California CA 92123 or by phoning (858) 637-7888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Redfern H Charles MD |
Contact Person: | H Charles Redfern |
Address: | 3075 Health Center Drive # 102, San Diego, California 92123 |
Phone Number: | (858) 637-7888 |
Website Address: | oncologysandiego.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Physicians Offices |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Redfern H Charles MD was started in 2004 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact H Charles Redfern for inquiries that concern Redfern H Charles MD by calling the company number (858) 637-7888, as your correspondence is most welcome. Additionally, the physical location of the single location of Redfern H Charles MD can be found at the coordinates 32.798524,-117.15608 as well as the street address 3075 Health Center Drive # 102 in San Diego, California 92123.
For its online presence, you may visit Redfern H Charles MD’s website at oncologysandiego.com and engage with its social media outlets through on Twitter and on Facebook.